Human T cell leukaemia virus type I (HTLV-I) provirus DNA was found to be methylated in patients with adult T cell leukaemia. We have therefore examined the possibility that DNA methylation might contribute to HTLV-I latency. In vitro methylation of HTLV-I long terminal repeat (LTR)-chloramphenicol acetyltransferase or LTR-Luciferase constructs at eight HpalI sites, a subset of the eukaryotic methylation site CpG, resulted in a three-to fourfold inhibition of transcription in transfected cells. Inhibition of transcription by methylation of all CpG methylation sites using SssI methylase was much more pronounced (50-to 80-fold). As partial methylation of the LTR showed, methylation of the promoter region was responsible for most of the effect. Whereas cellular stimulation by a combination of phorbol 12-myristate 13-acetate and Tax was able to reverse the HpaII methylation effect, the inhibition by SssI methylation was not suppressible under these conditions. The results are in line with a possible function of DNA methylation in HTLV-I latency.
Human T cell leukaemia virus type I (HTLV-I) is known as the aetiological agent of adult T cell leukaemia (ATL; Poiesz et al., 1980) and tropical spastic paraparesis (TSP; Gessain et al., 1985) . The expression of viral genes is regulated at the level of transcription, by the interplay of different cellular transcription factors and the viral transactivating factor Tax (Fujisawa et al., 1985; Sodroski et al., 1984) , and post-transcriptionally at the level of splicing and mRNA transport by the HTLV-I Rex protein (Hidaka et al., 1988) . The Tax protein stimulates viral transcription via an enhancer in the viral long terminal repeat (LTR) consisting of three incompletely repeated 21 bp repeats (Rosen et al., 1987; Brady et al., 1987) . Tax interacts indirectly with the enhancer by binding to cellular transcription factors (for example CREB, cAMP-responsive element binding protein) that recognize the enhancer (Suzuki et al., 1993) . Besides the transcription of viral genes, Tax also stimulates several cellular genes, among them interleukin 2 (IL-2) and IL-2 receptor ~ (IL-2R~; Inoue et al., 1986) , both containing NF-KB-responsive elements in their promoters. They are essential for the induction of T cell growth and are supposed to play an important role in the transformation of T cells by HTLV-I (Yoshida & Seiki, 1990) .
From present knowledge the following scenario of cell transformation by HTLV-I could be suggested: The induction of IL-2 and IL-2R~ by Tax may lead, by autocrine stimulation, to polyclonal T cell growth in primary HTLV-I infection. Most of the infected cells are probably eliminated by the immune system, but some, expressing little or no viral antigen, could escape the immune surveillance. The provirus genome could either become truly latent or induce more frequent or prolonged growth cycles of infected cells, making a final transformation event by mutation or translocation more likely.
Transformation in ATL is always clonal and evidently a rare event. Only about 1% of the carriers develop T cell leukaemia (Takatzuki et al., 1990) . The rest stay latent throughout the life of the carrier, with very few cells containing the provirus and viral expression efficiently down-regulated (Franchini et al., 1984) . Down-regulation probably results primarily from a lack of inducible transcription factors in quiescent T cells. In addition, as a more permanent mechanism of gene inactivation, DNA methylation may eventually become predominant. DNA methylation has broadly been accepted to have a function in the permanent shut-off of tissue-specific genes as well as viral genes in tissues in which they are inactive. As a rule, methylation of the promoter region of a gene leads to repression of transcription (Drrfler, 1983 ; Razin & Szyf, 1984; Cedar, 1988) .
DNA methylation of HTLV-I has been reported in ATL patients (Kitamura et al., 1985) and in infected cells in culture (Saggioro et al., 1990 Mock 22"9 (_+ 1"0) 0
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Here we have studied the effect of different DNA methylations on HTLV-I transcription using HTLV-I LTR~zhloramphenicol acetyltransferase (CAT) or HTLV-I LTR-Luciferase (Luc) constructs (pU3R-I and pHTPGL2, respectively), which were methylated with commercial methylases in vitro. Fig. 1 shows a representation of the HTLV-I LTR with the methylation sites, the 21 bp enhancer, the target site for phorbol 12-myristate 13-acetate (PMA) induction and the restriction sites used. It is evident that the number of methylation sites is threefold higher (10 %) in the region downstream of the transcription start than in the upstream promoter region (3.2 %). The average CpG density in the HTLV-I LTR (5.7 %) is considerably higher than the 1% or so in eukaryotic DNA and leads to the expectation of strong inhibition of HTLV-I transcription by methylation.
The following results were obtained in three to four independent experiments. For methylation with the different methylases, the LTR was excised with XhoI and HindIII, methylated separately (G6tz et al., 1990) and religated into the vector to exclude any eventual influence of the methylation of vector sequences. The religated HTLV-I LTR-CAT DNA (3 lag), methylated with SssI, HpaI! or HhaI, was transfected into HeLa cells together with 5 lag of the expression plasmid pECE-Tax, which contains the tax gene under the control of the early simian virus 40 promoter. Transfection was performed with Lipofectin (BRL) as described by Malone et al. (1989) and cells were harvested 48 h later as described by O'Hare & Hayward (1984) . CAT activity was assayed according to Seed & Shun (1988) . As shown in Table 1 , SssI methylation resulted in almost complete inhibition of transcription (98.8%), whereas the inhibition by HpalI methylation (67.9%) was much lower. HhaI methylation, with only three target sites in the downstream region and none in the promoter, showed no inhibition.
To determine whether methylation of the promoter region or of the more heavily methylated region downstream of the promoter contributed most to the inhibition effect, the LTR was divided into an upstream and a downstream fragment, which could be methylated separately and religated into the plasmid after methylation. For that purpose a PstI linker (GCTGCAGC) was introduced at the NdeI site of the HTLV-I LTR so that the fragments could be religated efficiently, and the LTR was transferred in front of the luciferase gene of pGL2 (Promega). The introduction of a PstI site did not alter the induction of the HTLV-I promoter by Tax or PMA (unpublished results). The DNA of the resulting plasmid PHTGL2 (4 lag), methylated in the promoter region or downstream of the promoter, was transfected into HeLa cells together with pECE-Tax DNA (5 lag) and Bluescript SK+ DNA (30 lag) by electroporation (Showe et al., 1992) . The cells were harvested 24 h later (Malone et al., 1989) and assayed for luciferase activity in a Berthold Lumat LB 9501 luminometer (Nguyen et al., 1988) .
As can be seen in Table 2 , methylation of the promoter caused a more pronounced inhibition than methylation of the downstream region, although the inhibition was somewhat lower than with methylation of the entire LTR. Therefore, methylation of both fragments seems necessary for complete suppression of transcription. To test how stable the methylation effect was under conditions of cellular activation, the cells were treated with PMA (10 lag/ml 48 h before harvesting) during transfection (Table 3) . HTLV-I LTR-CAT (2lag), methylated with HpaII or SssI methylase, was transfected by the Lipofectin method into HeLa cells which were cotransfected with pECE-Tax (5 lag), stimulated with PMA, or both cotransfected and stimulated. Although PMA alone did not reduce the methylation effect, in combination with Tax it was able to overcome the relatively slight inhibition effect by HpaII methylation. However, the more pronounced inhibition by SssI methylation was virtually unaltered.
To characterize the mechanism of transcription inhibition by methylation, we tried to distinguish between inhibition by interference with the binding of transcription factors (Becker et al., 1987; Bednarik et at., 1990; Iguchi-Ariga & Schaffner, 1989) and with the methyl group-binding protein MeCP1. MeCP1 has been described as a protein that binds to methyl groups regardless of DNA sequence, 15 methyl groups being the optimum for binding (Meehan et al., 1989) . But fewer methyl groups in a DNA sequence can also invoke binding, although with lower affinity (Boyes & Bird, 1992) . Binding of this ubiquitous nuclear protein has been shown to be competed for by highly methylated DNA in transient transfection experiments (Boyes & Bird, 1991; Levine et at., 1992) .
For the experiments in Table 4 , HTLV-I LTR-CAT (0-8 lag), methylated with HpaII or HpaII and HhaI methylase, and pECE-Tax (2 lag) were transfected into HeLa cells using Lipofectin, together with SssI-meth- et al., 1992) . In keeping with these results, it was shown by Iguchi-Ariga & Schaffner (1989) that methylation of the cAMP response element TGACGTCA inhibits factor binding and transcription.
The incomplete 21 bp repeats in the HTLV-I LTR contain cAMP binding sites differing from the above sequence by one, two and three nucleotides, respectively. However, mobility-shift electrophoretic analysis with crude HeLa nuclear proteins did not show any differences between methylated and unmethylated HTLV-I promoter DNA (unpublished results). They will have to be repeated with purified cAMP-responsive element binding protein.
As reported earlier by Saggioro et al. (1991) and confirmed by us, methylation with HpaII of the seven CCGG sequences in the LTR results in only a three-to fourfold inhibition of transcription. Whereas this partial methylation effect could be reversed by the combined treatment with PMA and Tax, the effect of complete methylation with SssI methylase remained irreversible under these conditions. These results lend support to the possibility that DNA methylation could function as an efficient latency mechanism in HTLV-I infection, reversible only by demethylation, a comparably rare event.
It would be interesting to know the degree of methylation in the HTLV-I LTR in latently infected carriers. So far, methylation of the HTLV-I LTR in vivo has only been reported from ATL patients (Kitamura et al., 1985) . Here, the LTR analysed for methylation by HpaII cutting was found to be under-methylated. However, the picture could be different in the cases of lifelong latency.
DNA methylation is not a primary inactivation mechanism for genes, but could perhaps best be regarded as an additional safety mechanism against reactivation, imposed on genes that have previously been inactivated, for example by lack of transcription factors. That proviral genomes of retroviruses can be inactivated by the process of de novo methylation has been amply documented (Guntaka et al., 1979; Cohen, 1980; Stuhlmann et al., 1981) . It has even been speculated that DNA methylation in higher eukaryotes could mainly serve the purpose of inactivating retroviral genes by mutation of 5-methylcytosine to thymine (Bird, 1986) . To establish the methylation pattern in HTLV-I carriers would require the use of PCR in combination with methylation-sensitive restriction enzymes (Singer-Sam et al., 1990) or in combination with the deamination of cytosines with bisulphite, cloning and sequencing (Frommer et at., 1992) . The first method would only yield the methylation status of methylation-sensitive restriction sites (such as HpaII sites), whereas the second method could give the complete methylation pattern, but does not yet seem to work with small amounts of DNA.
